ARS Pharmaceuticals, Inc. (SPRY)
4.565
+0.20
(+4.70%)
USD |
NASDAQ |
Oct 08, 16:00
4.64
+0.08
(+1.64%)
After-Hours: 20:00
ARS Pharmaceuticals Price : 4.565 for Oct. 8, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 07, 2026 | 4.24 | 4.402 | 4.205 | 4.36 | 1.298M |
| Oct 06, 2026 | 4.31 | 4.31 | 4.08 | 4.295 | 1.219M |
| Oct 05, 2026 | 4.13 | 4.395 | 4.03 | 4.29 | 1.622M |
| Oct 02, 2026 | 4.16 | 4.27 | 3.985 | 4.07 | 1.829M |
| Oct 01, 2026 | 4.35 | 4.395 | 4.11 | 4.12 | 1.972M |
| Sep 30, 2026 | 4.43 | 4.45 | 4.24 | 4.31 | 1.298M |
| Sep 29, 2026 | 4.11 | 4.435 | 4.01 | 4.40 | 1.275M |
| Sep 28, 2026 | 4.06 | 4.19 | 4.00 | 4.13 | 949893.0 |
| Sep 25, 2026 | 4.18 | 4.18 | 4.02 | 4.08 | 1.035M |
| Sep 24, 2026 | 4.21 | 4.24 | 4.07 | 4.15 | 1.053M |
| Sep 23, 2026 | 4.49 | 4.49 | 4.11 | 4.18 | 1.370M |
| Sep 22, 2026 | 4.40 | 4.57 | 4.36 | 4.48 | 1.268M |
| Sep 21, 2026 | 4.16 | 4.385 | 4.07 | 4.35 | 1.198M |
| Sep 18, 2026 | 4.10 | 4.20 | 4.10 | 4.11 | 1.886M |
| Sep 17, 2026 | 4.26 | 4.30 | 4.12 | 4.15 | 1.873M |
| Sep 16, 2026 | 4.25 | 4.365 | 4.125 | 4.165 | 1.452M |
| Sep 15, 2026 | 4.50 | 4.50 | 4.220 | 4.25 | 2.776M |
| Sep 14, 2026 | 4.80 | 4.90 | 4.455 | 4.50 | 2.167M |
| Sep 11, 2026 | 5.13 | 5.19 | 4.73 | 4.76 | 2.574M |
| Sep 10, 2026 | 5.20 | 5.22 | 5.02 | 5.06 | 1.091M |
| Sep 09, 2026 | 5.35 | 5.38 | 5.215 | 5.23 | 874546.0 |
| Sep 08, 2026 | 5.515 | 5.535 | 5.305 | 5.39 | 1.087M |
| Sep 04, 2026 | 5.60 | 5.70 | 5.54 | 5.62 | 852848.0 |
| Sep 03, 2026 | 5.86 | 5.90 | 5.605 | 5.67 | 1.088M |
| Sep 02, 2026 | 5.86 | 6.00 | 5.745 | 5.82 | 1.197M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Capricor Therapeutics, Inc. | 8.01 |
| Sionna Therapeutics, Inc. | 4.90 |
| Nektar Therapeutics | 40.74 |
| Vertex Pharmaceuticals, Inc. | 503.32 |
| Ardelyx, Inc. | 3.265 |
Price Related Metrics
| PS Ratio | 3.870 |
| PEG Ratio | -0.0061 |
| Price to Book Value | 36.28 |
| Earnings Yield | -47.60% |
| Market Cap | 453.93M |
| PEGY Ratio | -0.0061 |